图源:豆包5月6日,江苏省公共资源交易中心显示:信达生物的氟泽雷塞片已从24900元一瓶降至18600元,降幅达25.3%。氟泽雷塞片的降价并不意外。眼下正是国谈前夕,历年国谈前都会有一波药企主动下调药品价格,为医保谈判做准备。5月7日,信达生物向健识局确认:氟泽雷塞片会参与今年的国家医保目录调整。事实上,今年氟泽雷塞片必须一战。氟泽雷塞片去年8月获批,由信达生物和劲方医药共同研发商业化。它是国内...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.